Single infusion of myeloid progenitors reduces death from Aspergillus fumigatus following chemotherapy-induced neutropenia

Blood

Volumn 105, Issue 9, 2005, Pages 3535-3537

  BitMansour, Andrew ^a   Cao, Thai M ^a   Chao, Stephanie ^a   Shashidhar, Sumana ^a   Brown, Janice M Y ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL;

ADOLESCENT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPERGILLUS FUMIGATUS; CELL TRANSPLANTATION; CHEMOTHERAPY; CONTROLLED STUDY; GRANULOCYTE PRECURSOR; HEMATOPOIETIC STEM CELL; INFECTION PREVENTION; MONOCYTE; MOUSE; MYCOSIS; MYELOID PROGENITOR CELL; NEUTROPENIA; NEUTROPHIL; NONHUMAN; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; SURVIVAL;

EID: 18244373961     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2004-07-2676     Document Type: Article

References (14)

1. Manzullo EF. Sepsis: the role of steroids and monoclonal antibodies in treatment. Oncology. 1994;8:115-120.
2. Rowe JM, Andersen JW, Mazza JJ, et al. A randomized placebo-controlled phase II study of granulocyte-macrophage colony-stimulating factor in adult patients (> 55 to 70 years of age) with acute myelogenous leukemia: a study of the Eastern Cooperative Oncology Group (E1490). Blood. 1995;86:457-462.
3. Bishop MR, Tarantolo SR, Geller RB, et al. A randomized double-blind trial of filgrastim (granulocyte colony-stimulating factor) versus placebo following allogeneic blood stem cell transplantation. Blood. 2000;91:80-85.
4. Trillet-Lenoir V, Green J, Manegold C, et al. Recombinant granulocyte colony-stimulating factor reduces the infectious complications of cytotoxic chemotherapy. Eur J Cancer. 1993;29A:319-324.
5. Glasser L, Lane TA, McCullough J, et al. Neutrophil concentrates: functional considerations, storage, and quality control. J Clin Apheresis. 1983;1:179-184.
6. Price TH, Dale DC. Blood kinetics and in vivo chemotaxis of transfused neutrophils; effect of collection method, donor corticosteroid treatment, and short-term storage. Blood. 1979;54:1977-1986.
7. McCullough J, Weiblen BJ, Deinard AR, et al. In vitro function and post-transfusion survival of granulocytes collected by continous-flow centrifugation and filtration leukapheresis. Blood. 1976;48:315-326.
8. Akashi K, Traver D, Miyamoto T, et al. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature. 2000;404:193-197.
9. BitMansour A, Burns SM, Traver D, et al. Myeloid progenitors protect against invasive aspergillosis and Pseudomonas aeruginosa infection following hematopoietic stem cell transplantation. Blood. 2002;13:4660-4667.
10. Stroncek DF, Leonard K, Eiber G, et al. Alloimmunization after granulocyte transfusions. Transfusion. 1996;36:1009-1015.
11. Peters C, Minkov M, Matthes-Martin S, et al. Leucocyte transfusions from rhG-CSF or prednisolone stimulated donors for treatment of severe infections in immunocompromised neutropenic patients. Br J Haematol. 1999;106:689-696.
12. Dignani MC, Anaissie EJ, Hester JP, et al. Treatment of neutropenia-related fungal infections with granulocyte colony-stimulating factor-elicited white blood cell transfusions: a pilot study. Leukemia. 1997;11:1621-1630.
13. Bhatia S, McCullough J, Perry EH, et al. Granulocyte transfusions: efficacy in treating fungal infections in neutropenic patients following bone marrow transplantation. Transfusion. 1994;34:226-232.
14. Manz MG, Miyamoto T, Akashi K, et al. Prospective isolation of human clonogenic common myeloid progenitors. Proc Natl Acad Sci USA. 2002;99:11872-11877.